AEMCOLO

rifamycin SV MMX

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AEMCOLO, covering 2022-05-05 to 2022-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) [Phase 2]